Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • A step further towards...

    A step further towards developing Gonorrhea vaccine

    Written by Anjali Nimesh Nimesh Published On 2018-02-06T19:15:05+05:30  |  Updated On 18 Aug 2021 3:37 PM IST
    A step further towards developing Gonorrhea vaccine

    Gonorrhea, a sexually transmitted disease whose numbers grow by 78 million new cases worldwide each year, is highly damaging to reproductive and neonatal health if untreated or improperly treated.Dr.Aleksandra Sikora of Oregon State University and Nicholas Noinaj of Purdue University have been able to provide key structural and functional insights into a multicomponent protein complex BAM on outer membrane of the Neisseria gonorrhoeae.This s being seen as a step further towards developing Gonorrhea vaccine.


    The findings are especially important as Neisseria gonorrhoeae is considered a "superbug" because of its resistance to all classes of antibiotics available for treating infections.It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.


    Research led by co-corresponding authors Aleksandra Sikora of Oregon State University and Nicholas Noinaj of Purdue University provides key structural and functional insights into a multicomponent protein complex known as BAM, short for beta-barrel assembly machinery.In Gram-negative bacteria, BAM is responsible for the biogenesis of beta-barrel proteins on the cells' outer membranes.


    Outer membrane proteins have crucial physiological and structural functions, among them nutrient acquisition, secretion, signal transduction, outer membrane biogenesis, and motility. In pathogenic bacteria, those proteins also lead to host colonization and can exploit immune responses, facilitating virulence.


    BamA is the beta-barrel assembly machinery's primary component, and this study took a look at two other components, BamD and BamE.


    Researchers found that in N. gonorrhoeae, BamE is exposed on the cell surface but is not essential for cell viability. Conversely, BamD had the opposite traits: Not surface displayed, yet essential for viability.


    However, when BamE was knocked out in experiments, BamD moved to the surface.


    "The loss of BamE altered cell envelope composition and led to slower cell growth," said Sikora, associate professor in the OSU College of Pharmacy. "It also led to an increase in both antibiotic susceptibility and the formation of membrane vesicles containing greater amounts of vaccine antigens."


    Sikora noted that both BamD and BamE are expressed in diverse gonococcal isolates and throughout different phases of growth.


    "The solved structures of Neisseria BamD and BamE share overall folds with E. coli proteins but there are also differences that may be important for function," she said. "So even though BAM is conserved across Gram-negative bacteria, there are structural and functional differences from species to species that can likely be exploited in developing species-specific therapeutics to combat multidrug resistance."


    For example, in E. coli, BamE is not surface exposed; also, the absence of BamE in E. coli does not lead BamD to become displayed on the outer membrane.


    "That's further evidence that BamE may be a new vaccine target against N. gonorrhoeae," Sikora said. "We did a lot of biology as well as structure solving that give us tools for enabling new therapies. In the battle against multidrug resistance, the ideal way of preventing disease is a vaccine, and having a structure of BamE opens the door to a structural vaccinology approach."


    For more details click on the link : http://dx.doi.org/10.1074/jbc.RA117.000437
    ectopic pregnancyEpididymitisGonococcalgonorrhea vaccinegonorrhoeae bacteriaInfectionsinfertilitymultidrug resistancepelvic inflammatory diseaseVaccine
    Source : Eureka Alert

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok